Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

A Pilot Study Examining the Prognostic Utility of Tumor Shrinkage on Cone-Beam Computed Tomography (CBCT) for Stage III Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Definitive Chemoradiation

Bibliographic Data

ID15513596
AuthorsKylie H Kang (0000-0002-4484-3689), Jimmy T Efird (0000-0002-4890-5111, corresponding author), Tarun K Podder (0000-0002-2925-1431, University School), Yuxia Zhang (0000-0003-4419-7004, University School), Afshin Dowlati (0000-0003-4535-6839, Case Comprehensive Cancer Center), Mitchell Machtay (0000-0002-0423-1231, University School), Charulata Jindal (0000-0001-9522-9702, University of Newcastle Australia), Tithi Biswas (0009-0000-8253-2876, University School)
Year2021
Volume18
Issue6
Pages3241-3241
Publication date2021-03-21
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueInternational Journal of Environmental Research and Public Health (JOURNAL)
Journal identifiersISSN: 1661-7827 • E-ISSN: 1660-4601
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/ijerph18063241
PMID33801033
OpenAlexW3136493108
LanguageEN

There has been growing interest in utilizing information from cone-beam computed tomography (CBCT) to help guide both treatment delivery and prognosis. In this assessment of locally advanced unresectable stage III non-small cell lung cancer (NSCLC) treated with definitive chemoradiation, we aimed to determine the survival advantage associated with using CBCT to measure tumor regression. Patient, tumor, and treatment characteristics were collected. The serial tumor shrinkage for each patient was determined from tumor volume contours on weekly CBCTs. Survival analysis was performed using the Kaplan-Meier technique and a Cox proportional hazards model. At least two-thirds of patients had a tumor volume reduction of at least 5% after each week of chemoradiation. A weekly reduction in tumor volume of 5% or greater seen on the CBCT images during radiation therapy was significantly associated with improved overall survival, which remained significant when adjusted for age, histology, grade, and T- and N-stages ( p = 0.0036). Additionally, the presence of N3 disease was associated with a five-fold increased risk of recurrence ( p = 0.0006) and a nearly three-fold increased risk of death ( p = 0.053) compared with N0-N2 disease. Tumor volume shrinkage observed in the CBCT images during definitive chemoradiation holds promise as a prognostic indicator of stage III NSCLC, especially given its affordability, availability, and applicability. Further evaluation in a prospective fashion is warranted to validate the tumor volume shrinkage and its clinical utility

Cancer · Chemoradiotherapy · Computed tomography · Cone beam computed tomography · Lung cancer · Nuclear medicine · Proportional hazards model · Prospective cohort study · Radiation therapy · Radiology · Shrinkage · Stage (stratigraphy · Survival analysis · Lung Cancer Diagnosis and Treatment · Medical Imaging Techniques and Applications · Medicine · Radiomics and Machine Learning in Medical Imaging · Internal Medicine · Oncology

Citation velocityhistorical
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae